Exhibit 8.1
ELLENOFF GROSSMAN & SCHOLE LLP
1345 AVENUE OF THE AMERICAS
NEW YORK, NEW YORK 10105
TELEPHONE: (212) 370-1300
FACSIMILE: (212) 370-7889
www.egsllp.com
October 18, 2021
Healthcare Capital Corp.
301 North Market Street, Suite.1414
Wilmington, Delaware 19801
Ladies and Gentlemen:
We are United States counsel to Healthcare Capital Corp., a Delaware corporation (the “SPAC”), in connection with the preparation of the registration statement on Form F-4 (and together with the Proxy Statement/Prospectus filed therewith, the “Registration Statement”) (Registration No. 333-258915) originally filed with the Securities and Exchange Commission (the “Commission”) on August 18, 2021, under the Securities Act of 1933, as amended (the “Securities Act”), by Alpha Tau Medical Ltd., a company organized under the laws of the State of Israel (the “Company”). The Registration Statement relates to the registration of 33,343,750 ordinary shares of the Company, par value $0.0001 per share, 19,530,000 warrants, and 19,530,000 ordinary shares underlying warrants, as part of the Business Combination.
The Registration Statement is being filed in connection with the transactions contemplated by the Agreement and Plan of Merger, dated as of July 7, 2021 (the “Merger Agreement”), by and among the SPAC, the Company, and Archery Merger Sub Inc., a Delaware corporation and wholly-owned subsidiary of the Company (“Merger Sub”) (such transactions, the “Business Combination”).
Capitalized terms not otherwise defined herein shall have the same meanings attributed to such terms in the Registration Statement.
You have requested our opinion concerning the discussion of the Business Combination set forth in the section entitled “Certain Material U.S. Federal Income Tax Considerations — U.S. Holders” and the section entitled “Certain Material U.S. Federal Income Tax Considerations — Non-U.S. Holders” in the Registration Statement (the “Tax Disclosure”). In providing this opinion, we have assumed (without any independent investigation or review thereof) that:
a. All original documents submitted to us (including signatures thereto) are authentic, all documents submitted to us as copies conform to the original documents, all such documents have been duly and validly executed and delivered where due execution and delivery are a prerequisite to the effectiveness thereof, and all parties to such documents had or will have, as applicable, the requisite corporate powers and authority to enter into such documents and to undertake and consummate the Business Combination;
b. All factual representations, warranties, and statements made or agreed to by the parties to the Merger Agreement, the Sponsor Support Agreement, the PIPE Agreements, the Joinder, the Amended Investors’ Rights Agreement, the Company Shareholder Support Agreements, the Plan of Merger, and the other agreements referred to in each of the foregoing (collectively, the “Agreements” and, together with the Registration Statement, the “Documents”), and in the representation letters provided to us by SPAC and the Company are true, correct, and complete as of the date hereof and will remain true, correct, and complete through the consummation of Transactions (as defined below), in each case without regard to any qualification as to knowledge, belief, materiality, or otherwise;